National Institute of Mental Health (U.S.)
-
Subject Areas on Research
-
3-year follow-up of the NIMH MTA study.
-
A summary of the FDA-NIMH-MATRICS workshop on clinical trial design for neurocognitive drugs for schizophrenia.
-
Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria.
-
Clinical science and biomarkers: against RDoC.
-
Comorbidity of depression with other medical diseases in the elderly.
-
Comorbidity of late life depression: an opportunity for research on mechanisms and treatment.
-
Depression and dysphoria among the elderly: dispelling a myth.
-
Developing methodologies for monitoring long-term safety of psychotropic medications in children: report on the NIMH conference, September 25, 2000.
-
Development and natural history of mood disorders.
-
Diagnostic criteria for psychosis in Parkinson's disease: report of an NINDS, NIMH work group.
-
Effects of antipsychotic medications on psychosocial functioning in patients with chronic schizophrenia: findings from the NIMH CATIE study.
-
Exclusion criteria of DSM-III. A study of co-occurrence of hierarchy-free syndromes.
-
Functional co-primary measures for clinical trials in schizophrenia: results from the MATRICS Psychometric and Standardization Study.
-
Integrating primary health care and mental health services: a preliminary report.
-
Lack of understanding of acute HIV infection among newly-infected persons-implications for prevention and public health: The NIMH Multisite Acute HIV Infection Study: II.
-
Lessons learned about behavioral science and acute/early HIV infection. The NIMH Multisite Acute HIV Infection Study: V.
-
Mental health services system research: the National Institute of Mental Health program.
-
Methodologic issues in maintenance therapy clinical trials.
-
National Institute of Mental Health Collaborative Multimodal Treatment Study of Children with ADHD (the MTA). Design challenges and choices.
-
Perspectives on depression, mild cognitive impairment, and cognitive decline.
-
Psychosocial treatment strategies in the MTA study: rationale, methods, and critical issues in design and implementation.
-
Report card on the National Plan for Research on Child and Adolescent Mental Disorders. The midway point.
-
Report from the working group conference on multisite trial design for cognitive remediation in schizophrenia.
-
Rigor and reproducibility in research with transcranial electrical stimulation: An NIMH-sponsored workshop.
-
Strategies used in the detection of acute/early HIV infections. The NIMH Multisite Acute HIV Infection Study: I.
-
Substance use and psychosocial functioning in schizophrenia among new enrollees in the NIMH CATIE study.
-
The FDA-NIMH-MATRICS guidelines for clinical trial design of cognitive-enhancing drugs: what do we know 5 years later?
-
The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity.
-
The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization.
-
The NIMH Child Emotional Faces Picture Set (NIMH-ChEFS): a new set of children's facial emotion stimuli.
-
The NIMH Epidemiologic Catchment Area program. Historical context, major objectives, and study population characteristics.
-
The NIMH Multisite HIV Prevention Trial: reducing HIV sexual risk behavior. The National Institute of Mental Health (NIMH) Multisite HIV Prevention Trial Group.
-
The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development.
-
Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report.
-
Use of ECT in the United States in 1975, 1980, and 1986.
-
What have we learned about trial design from NIMH-funded pragmatic trials?